CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 54,342,875
- Share change
- +439,070
- Total reported value
- $235,299,521
- Put/Call ratio
- 138%
- Price per share
- $4.33
- Number of holders
- 106
- Value change
- -$5,313,006
- Number of buys
- 41
- Number of sells
- 67
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13F
|
Company |
3.7%
|
6,303,025
|
$32,082,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
5,516,321
|
$28,078,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3%
|
5,052,601
|
$25,718,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
4,036,937
|
$20,548,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.1%
|
3,500,000
|
$17,815,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
2%
|
3,305,940
|
$16,826,000 | — | 30 Sep 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.9%
|
3,269,112
|
$16,639,000 | — | 30 Sep 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.1%
|
1,821,868
|
$9,273,000 | — | 30 Sep 2021 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.89%
|
1,500,000
|
$7,635,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.83%
|
1,400,939
|
$7,131,000 | — | 30 Sep 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.82%
|
1,394,070
|
$7,096,000 | — | 30 Sep 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.73%
|
1,233,642
|
$6,279,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
1,123,083
|
$5,716,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,109,065
|
$5,645,000 | — | 30 Sep 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.64%
|
1,078,103
|
$5,488,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.62%
|
1,045,607
|
$5,322,000 | — | 30 Sep 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.57%
|
961,597
|
$4,895,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.55%
|
936,848
|
$4,769,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.53%
|
894,600
|
$4,554,000 | — | 30 Sep 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.41%
|
700,990
|
$3,565,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.39%
|
662,665
|
$3,373,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
654,686
|
$3,333,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.23%
|
388,320
|
$1,977,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
323,029
|
$1,644,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.19%
|
320,266
|
$1,630,000 | — | 30 Sep 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.15%
|
261,050
|
$1,329,000 | — | 30 Sep 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
249,146
|
$1,268,000 | — | 30 Sep 2021 | |
| AXA S.A. |
13F
|
Company |
0.14%
|
231,600
|
$1,179,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
223,466
|
$1,169,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
210,087
|
$1,069,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
201,200
|
$1,024,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.1%
|
166,410
|
$846,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
164,258
|
$837,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
158,301
|
$806,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
157,173
|
$800,000 | — | 30 Sep 2021 | |
| VIRGINIA RETIREMENT SYSTEMS ET Al |
13F
|
Company |
0.09%
|
150,300
|
$765,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.09%
|
149,176
|
$759,000 | — | 30 Sep 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.07%
|
125,000
|
$636,000 | — | 30 Sep 2021 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.07%
|
124,356
|
$634,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
121,686
|
$620,000 | — | 30 Sep 2021 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.07%
|
120,000
|
$611,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
118,194
|
$601,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
116,200
|
$591,000 | — | 30 Sep 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
112,816
|
$574,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
110,853
|
$564,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
109,469
|
$557,000 | — | 30 Sep 2021 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
106,900
|
$544,000 | — | 30 Sep 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.06%
|
105,808
|
$539,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
101,854
|
$518,000 | — | 30 Sep 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.06%
|
99,371
|
$506,000 | — | 30 Sep 2021 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q4 2021
As of 31 Dec 2021,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,342,875 shares.
The largest 10 holders included
Point72 Asset Management, L.P., RTW INVESTMENTS, LP, BVF INC/IL, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, STATE STREET CORP, Rubric Capital Management LP, Candriam Luxembourg S.C.A., and MILLENNIUM MANAGEMENT LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
111
Q4 2021 holders
106
Holder diff
-5
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.